v3.25.2
Segment Reporting - Schedule of Segment Profitability that are Most Relied Upon by the CODM are Gross Revenue and Net Loss (Details) - CODM [Member] - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Schedule of Segment Profitability that are Most Relied Upon by the Codm are Gross Revenue and Net Loss [Line Items]        
Revenue $ 34,095 $ 6,174 $ 42,206 $ 7,541
Operating Costs        
Compensation and benefits 50,292 6,687 85,987 8,836
Professional and consulting fees 1,206 461 2,627 1,418
Data processing 177 239 359 420
Other (income)/expenses 1,846 1,523 4,669 2,408
Loss from operations (19,426) (2,736) (51,436) (5,541)
Other (expenses) income        
Interest income 364 285 423 449
Gain on marketable securities 5,042 104 3,964 678
Unrealized loss on note receivable   (742) 221 (1,657)
Change in fair value of investments 31,680 (3,031) 32,000 (5,490)
Total other (expenses) income 37,086 (3,384) 36,608 (6,020)
Net loss 17,660 (6,120) (14,828) (11,561)
Noncontrolling interests 1,050   1,050  
Net gain attributable to common stock holders of Dominari Holdings 16,610   (15,878)  
Total assets 108,288 49,073 108,288 49,073
Dominari Financial [Member]        
Schedule of Segment Profitability that are Most Relied Upon by the Codm are Gross Revenue and Net Loss [Line Items]        
Revenue 34,095 5,503 42,206 6,870
Operating Costs        
Compensation and benefits 30,540 4,962 37,430 6,384
Professional and consulting fees 711 293 1,358 761
Data processing 177 227 359 375
Other (income)/expenses (742) 847 733 1,370
Loss from operations 3,409 (826) 2,326 (2,020)
Other (expenses) income        
Interest income 364 205 381 341
Gain on marketable securities 4,236 3,326
Unrealized loss on note receivable  
Change in fair value of investments
Total other (expenses) income 4,600 205 3,707 341
Net loss 8,009 (621) 6,033 (1,679)
Noncontrolling interests 1,050   1,050  
Net gain attributable to common stock holders of Dominari Holdings 6,959   4,983  
Total assets 44,976 17,361 44,976 17,361
Legacy AIkido Pharma [Member]        
Schedule of Segment Profitability that are Most Relied Upon by the Codm are Gross Revenue and Net Loss [Line Items]        
Revenue 671 671
Operating Costs        
Compensation and benefits 19,752 1,725 48,557 2,452
Professional and consulting fees 495 168 1,269 657
Data processing 12 45
Other (income)/expenses 2,588 676 3,936 1,038
Loss from operations (22,835) (1,910) (53,762) (3,521)
Other (expenses) income        
Interest income 80 42 108
Gain on marketable securities 806 104 638 678
Unrealized loss on note receivable   (742) 221 (1,657)
Change in fair value of investments 31,680 (3,031) 32,000 (5,490)
Total other (expenses) income 32,486 (3,589) 32,901 (6,361)
Net loss 9,651 (5,499) (20,861) (9,882)
Noncontrolling interests    
Net gain attributable to common stock holders of Dominari Holdings 9,651   (20,861)  
Total assets $ 63,312 $ 31,712 $ 63,312 $ 31,712